SGNA and AORN leadership recently spoke at the public advisory committee of the FDA to address the nursing perspective and effective solutions regarding the issues with duodenoscope-related transmission of pathogens. Here are the summary sites:
top of page
(980) 236-8290
Search
Recent Posts
See AllThe FDA has now finalized the 2024 guidance for 510(k) information required for sterilization of reusable medical devices with some...
This article begins to highlight the need for effective contract performance documentation and evaluation. You must place specific,...
Post: Blog2_Post
bottom of page
Comments